This inventor holds 2 USPTO granted patents. Top assignees: Novo Nordisk A/s, Novo Nordisk Healthcare Ag. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Silke Møller Larsen: Innovator in Pharmaceutical Formulations
Introduction
Silke Møller Larsen is a notable inventor based in Charlottenlund, Denmark. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of GLP-1 compounds and human growth hormone formulations. With a total of 2 patents, his work has had a considerable impact on medical science.
Latest Patents
Silke's latest patents include a stable formulation of modified GLP-1, which focuses on pharmaceutical formulations of GLP-1 compounds and methods for their preparation. Another important invention is an aqueous pharmaceutical formulation that comprises human growth hormone, histidine, poloxamer, phenol, and mannitol. These innovations are crucial for advancing treatment options in various medical conditions.
Career Highlights
Throughout his career, Silke has worked with prominent companies such as Novo Nordisk A/S and Novo Nordisk Healthcare AG. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and contribute to groundbreaking research.
Collaborations
Silke has collaborated with talented individuals in his field, including James M. Flink and Simon Bjerregaard Jensen. These partnerships have fostered innovation and enhanced the quality of his work.
Conclusion
Silke Møller Larsen's contributions to pharmaceutical formulations demonstrate his commitment to advancing medical science. His patents and collaborations reflect a dedication to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile